Recent Updates
Recently added Catalysts
IMMP

Eftilagimod Alpha (LAG-3Ig or IMP321) Pre-IND Meeting with the FDA

Tuesday, November 14, 2017 1 min read
Key Takeaway: Eftilagimod Alpha (LAG-3Ig or IMP321) Pre-IND Meeting with the FDA

Full Press Release Details

Eftilagimod Alpha (LAG-3Ig or IMP321) Pre-IND Meeting with the FDA.
Tags: IMMP Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Nov 14, 2017